BANK OF MONTREAL /CAN/ - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 115 filers reported holding AKERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$769,000
+6890.9%
69,653
+17991.7%
0.00%
Q1 2021$11,000
-81.7%
385
-81.7%
0.00%
Q4 2020$60,000
+233.3%
2,099
+234.8%
0.00%
Q3 2020$18,000
-50.0%
627
-30.0%
0.00%
Q2 2020$36,000
-84.7%
896
-91.6%
0.00%
Q4 2019$236,000
-0.8%
10,625
+2.0%
0.00%
Q3 2019$238,00010,4180.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$179,29657.03%
Redmile Group, LLC 2,632,912$144,283,5785.90%
Avidity Partners Management LP 3,825,000$209,610,0004.54%
COMMODORE CAPITAL LP 537,076$29,4324.44%
Atlas Venture Life Science Advisors, LLC 594,251$32,564,9553.92%
Paradigm Biocapital Advisors LP 604,544$33,129,0113.89%
Yiheng Capital Management, L.P. 1,468,905$80,495,9943.56%
Altium Capital Management LP 125,000$6,850,0003.48%
Tri Locum Partners LP 128,851$7,061,0002.86%
SILVERARC CAPITAL MANAGEMENT, LLC 172,100$9,431,0802.70%
View complete list of AKERO THERAPEUTICS INC shareholders